SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+9.08%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$233M
AUM Growth
+$233M
(-19%)
Cap. Flow
-$85.7M
Cap. Flow
% of AUM
-36.74%
Top 10 Holdings %
Top 10 Hldgs %
36.18%
Holding
60
New
18
Increased
2
Reduced
24
Closed
14
Top Buys
| 1 |
SPDR S&P Biotech ETF
XBI
|
$11.2M |
| 2 |
Elevance Health
ELV
|
$8.11M |
| 3 |
Universal Health Services
UHS
|
$7.78M |
| 4 |
Pfizer
PFE
|
$5.91M |
| 5 |
AbbVie
ABBV
|
$5.42M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$26.4M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$10.3M |
| 3 |
Medtronic
MDT
|
$10M |
| 4 |
Smith & Nephew
SNN
|
$8.57M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
$8.1M |
Sector Composition
| 1 | Healthcare | 95.2% |
| 2 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Bristol-Myers Squibb
BMY
$96B
| $4.37M | 1.87% |
+70,000
| New | +$4.37M |
|
27
IQVIA
IQV
$32.4B
| $4.23M | 1.81% |
15,000
-20,000
| -57% | -$5.64M |
|
28
Molina Healthcare
MOH
$9.8B
| $3.98M | 1.7% |
12,500
-7,500
| -38% | -$2.39M |
|
29
Option Care Health
OPCH
$4.65B
| $3.7M | 1.58% |
130,000
-25,000
| -16% | -$711K |
|
30
Intuitive Surgical
ISRG
$170B
| $3.67M | 1.57% |
+10,199
| New | +$3.67M |
|
31
BioMarin Pharmaceuticals
BMRN
$11.2B
| $3.53M | 1.51% |
40,000
-25,000
| -38% | -$2.21M |
|
32
West Pharmaceutical
WST
$17.8B
| $3.52M | 1.51% |
+7,500
| New | +$3.52M |
|
33
Stryker
SYK
$150B
| $3.34M | 1.43% |
12,500
| – | – |
|
34
Community Health Systems
CYH
$387M
| $3.32M | 1.42% |
249,768
-65,232
| -21% | -$868K |
|
35
Cardinal Health
CAH
$35.5B
| $3.09M | 1.32% |
+60,000
| New | +$3.09M |
|
36
Hologic
HOLX
$14.9B
| $3.06M | 1.31% |
40,000
-20,000
| -33% | -$1.53M |
|
37
Select Medical
SEM
$1.61B
| $2.65M | 1.13% |
90,000
-110,000
| -55% | -$3.23M |
|
38
Guardant Health
GH
$8.41B
| $2.5M | 1.07% |
+25,000
| New | +$2.5M |
|
39
Natera
NTRA
$23.1B
| $2.34M | 1% |
+25,000
| New | +$2.34M |
|
40
Sarepta Therapeutics
SRPT
$1.78B
| $2.25M | 0.96% |
+25,000
| New | +$2.25M |
|
41
Encompass Health
EHC
$12.3B
| $1.96M | 0.84% |
30,000
-70,000
| -70% | -$4.57M |
|
42
Edwards Lifesciences
EW
$47.8B
| $1.95M | 0.84% |
+15,068
| New | +$1.95M |
|
43
CRISPR Therapeutics
CRSP
$4.71B
| $1.9M | 0.81% |
+25,000
| New | +$1.9M |
|
|
MRTX
44
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.46M | 0.62% |
+9,918
| New | +$1.46M |
|
|
BPMC
45
DELISTED
Blueprint Medicines
BPMC
| $1.07M | 0.46% |
+10,000
| New | +$1.07M |
|
46
Acadia Healthcare
ACHC
$2.12B
| – | – |
-18,893
| Closed | -$1.21M |
|
47
Bruker
BRKR
$5.16B
| – | – |
-75,000
| Closed | -$5.86M |
|
48
Centene
CNC
$14.3B
| – | – |
-100,000
| Closed | -$6.23M |
|
49
Quest Diagnostics
DGX
$20.3B
| – | – |
-6,000
| Closed | -$3.63M |
|
50
Grifois
GRFS
$6.78B
| – | – |
-200,000
| Closed | -$2.92M |
|